cenersen
Term · Oncology and biomedicine · MLC-T-ONC-012511
A phosphorothioate oligonucleotide harboring nucleotide sequences complementary to tumor suppressor p53 mRNA. Cenersen hybridizes with p53 mRNA molecules, and induces Rnase H dependent hydrolysis of p53 transcripts in the double stranded section of the hybrids, thereby resulting in loss of p53 production. Loss of p53 activity leads to sensitization of cancer cells to other therapeutics.
| Identifier | MLC-T-ONC-012511 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | OL(1)p53 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012511",
"term": "cenersen",
"field": "Oncology and biomedicine",
"definition": "A phosphorothioate oligonucleotide harboring nucleotide sequences complementary to tumor suppressor p53 mRNA. Cenersen hybridizes with p53 mRNA molecules, and induces Rnase H dependent hydrolysis of p53 transcripts in the double stranded section of the hybrids, thereby resulting in loss of p53 production. Loss of p53 activity leads to sensitization of cancer cells to other therapeutics.",
"synonyms": [
"OL(1)p53"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cenersen/"
}
Record 4,577 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.